Repligen Corp(RGEN)
270.39
Change: 0 (0)
As of Wed 10/06/2021 03:02 AM% Of Value
Growth
Value Per Share
:
:
:
3668.79
83.08
7.3700 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
Open | 94.24 | Dividend | 34 |
Close Price | 270.39 | DivYield | 0 % |
High | 95.09 | Growth | 0.0 |
Low | 93.0735 | Growth% | 83.08 |
P/e | 165.991 | Volume | 150,616.0 |
P/b | 0.25 | Market Capital | 14.8 B |
Highest High | 45.34 | Lowest Low | 28.82 |
50 Days Moving Average | 76.99 (as of 21/07/2019) | 50 Days Moving Average Percentage | -22.386 (as of 21/07/2019 |
Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
Revenue | 141.2 M | 194.0 M | 270.2 M | 366.2 M | 670.5 M |
Cap Spending | -5.4 M | -12.7 M | -23.1 M | -26.3 M | -71.2 M |
Operating Expenses | 60.1 M | 81.5 M | 115.0 M | 139.8 M | 224.0 M |
Operating Cash Flow | 14.0 M | 25.9 M | 36.0 M | 69.8 M | 167.2 M |
Free Cash Flow | 11.9 M | 19.9 M | 44.0 M | 36.2 M | 47.7 M |
Free Cash Flow Per Share | 0.314 | 0.457 | 0.911 | 0.69 | 0.868 |
Total liabilities | 99.2 M | 103.4 M | 263.3 M | 275.4 M | 366.0 M |
Total cash | 173.7 M | 193.8 M | 537.4 M | 717.2 M | 603.8 M |
ROE% | 0.074 | 0.027 | 0.024 | 0.05 | 0.077 |
Outstanding Shares | 43.5 M | 43.9 M | 52.0 M | 54.7 M | 55.3 M |
P/E | 53.776 | 165.991 | 207.157 | 197.036 | 78.671 |
P/S | 10.796 | 14.216 | 16.413 | 32.238 | 15.052 |
Revenue USD | 141.2 M | 194.0 M | 270.2 M | 366.2 M | 670.5 M |
NO REPORTS FOR THIS STOCK |
Latest Searches
Stock | Close Price | %of value | Date |
---|